.png)
← All articlesIf you have typed "GLP-1 near me" into a search bar, you already know the medicine exists. The harder question is who should be prescribing it. The short answer: a licensed provider who reviews your health history and labs before writing anything, who sources the medication from a state-licensed pharmacy, who follows the FDA label's dose schedule, and who checks in with you every month while you are on it. Anyone offering a weekly shot without those four things is selling a product, not running a program. This guide explains what to look for, what to avoid, and what a supervised medical weight loss program in Tarzana actually involves, so that the closest option is also a safe one.
For about two years, GLP-1 medications were on the FDA's drug shortage list, which allowed compounding pharmacies to make copies for patients who could not get the approved products. That window has closed. The FDA's shortage database now lists both semaglutide injection and tirzepatide injection as resolved, and the agency's position is that compounding is appropriate only when an FDA-approved drug cannot meet a patient's medical need or is not commercially available. In plain terms, the era of ordering a vial from a website with a five-question form is ending, and the providers still doing it are the ones to be careful with.
The FDA has been unusually direct about what went wrong during the shortage years. As of May 31, 2026, it had received 990 adverse event reports tied to compounded semaglutide and more than 730 tied to compounded tirzepatide, and it says those figures likely undercount the problem because state-licensed pharmacies that are not outsourcing facilities are not required to report. Many of the serious cases came from dosing errors: patients drawing the wrong amount from a vial, prescribers writing doses above the approved label, or titration schedules that moved faster than the label allows. The FDA also flagged products made with semaglutide "sodium" or "acetate" salt forms, which are not the same active ingredient as the approved drugs, and counterfeit pens in the U.S. supply.
None of that means the medication is unsafe when prescribed properly. It means the source and the supervision are the whole story. A provider you can drive to, who answers the phone, and who is accountable under California licensing is worth more than a few dollars saved on a shipped vial. If you want the clinical background first, our guide to how a supervised weight loss program works covers it.
The FDA's own advice to patients is simple: get a prescription from your doctor and fill it at a state-licensed pharmacy. A good local provider adds structure around that advice.
The approved dosing schedule is not a suggestion, and it is the easiest way to tell a careful provider from a careless one. For semaglutide, the label starts at 0.25 mg once weekly for four weeks, then 0.5 mg for four weeks, then 1 mg, then 1.7 mg, with the maintenance dose reached from week 17 onward. If a step is not tolerated, the label says to delay the next increase by four weeks. Tirzepatide follows a similar monthly step-up. The reason is tolerability: the most common side effects in the trials, reported in five percent or more of patients, were nausea, vomiting, diarrhea, abdominal pain and constipation, and they cluster around dose increases.
A provider who starts you at a high dose, moves you up every two weeks, or lets you decide the dose yourself is working outside the label. So is one who hands you a multi-dose vial and a bag of syringes without teaching you how to measure. The FDA's dosing-error reports came from exactly that setup: confusion between milligrams, milliliters and "units" on a syringe. If your provider uses vials, you should leave the first appointment knowing your exact volume, having drawn it up once in front of someone, and knowing that an opened multi-dose vial is discarded 28 days after first use with a fresh sterile needle for every dose.
Monthly check-ins are where the program earns its keep. That is when the dose is held or advanced, side effects are managed before they become reasons to quit, and the plan is adjusted. Our article on which GLP-1 side effects are normal and which are not explains what belongs in a check-in and what belongs in an urgent call.
The FDA's patient guidance reads like a checklist of the worst offenders, so it is worth repeating with local context.
Spelling errors on the pharmacy label, a pharmacy name you cannot verify with the California State Board of Pharmacy, and a "provider" who only exists as a chat window are the other tells. None of these are subtle once you know to look.
Telehealth is not the enemy. Plenty of good programs run virtually, and a from-home consult is a reasonable first step. The difference is accountability and follow-through. A clinic in Tarzana can draw your labs at a Quest near you, run the body composition scan in person, show you how to inject, and see you in the room when something is not going well. A national telehealth company cannot do most of that, and when it ships compounded medication from an out-of-state pharmacy, the FDA's adverse event data is a reminder of where the risk sits. If you live in Encino, Woodland Hills or Sherman Oaks, "near me" genuinely is an option.
The question to ask any provider, local or virtual: who is my prescriber, what is their license, which pharmacy fills this, and what happens at month one, three and six? A program that answers all four without hesitation is the one to choose. A program that answers with a price is not. At Contour Medical Clinic, the program starts with a free provider consultation, moves to baseline labs and a body composition scan, and then runs on monthly check-ins with the dose adjusted to how you respond. Which medication fits, if any, is the provider's decision, and our comparison of tirzepatide and semaglutide explains the factors that go into it.
The FDA lists both injectable drugs as no longer in shortage, so the broad allowance for compounded copies has ended. Compounding may still be appropriate when an approved product cannot meet a specific patient's medical need, which is a decision for the prescriber and a state-licensed pharmacy, not a website. Ask any provider offering a compounded version what the patient-specific reason is.
The label does not mandate a specific panel, but a responsible provider orders one. Kidney and liver function, glucose, A1c and lipids establish a baseline, screen for problems the label warns about, and give the monthly check-ins something to compare against. Labs also catch the medication interactions that matter, especially for anyone on insulin or a sulfonylurea.
For semaglutide the FDA label is one step every four weeks: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, then the maintenance dose from week 17. If a step is not tolerated, the label says to hold for another four weeks. Faster schedules are outside the label and are where many of the reported dosing problems came from.
Plateaus are common and are a reason to adjust the plan, not to abandon it. The provider looks at dose, protein intake, training, sleep and the body composition trend before deciding what changes. Our post on GLP-1 weight loss plateaus walks through that process.
Cost is a fair question to ask on the call. What a local program buys you is a prescriber you can reach, labs drawn near you, in-person injection training, a body composition scan, and someone accountable under California licensing. The FDA's advice to fill prescriptions at a state-licensed pharmacy and to avoid sellers that skip clinician screening is the standard to hold any program to, whatever it costs.
"GLP-1 near me" should lead you to a provider, not a product. Look for a licensed clinician who screens you against the label, orders baseline labs, sources from a state-licensed pharmacy, follows the monthly dose schedule, and sees you every month. Those five things are what separate a medical weight loss program from a shipped vial, and they are the reason the outcomes differ. If you are in Tarzana or the surrounding Valley and want to know whether a supervised program fits, take the two-minute weight loss check. Our provider reviews it and decides on the next step with you on a free call.
Written by: Contour Medical Clinic Editorial Team